Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,888 | 116 | 68.7% |
| Consulting Fee | $2,020 | 3 | 28.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $200.00 | 1 | 2.8% |
| Unspecified | $12.03 | 1 | 0.2% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. | $2,367 | 13 | $0 (2024) |
| NEW WORLD MEDICAL,INC. | $999.83 | 1 | $0 (2018) |
| Alcon Vision LLC | $750.50 | 29 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $517.70 | 12 | $0 (2024) |
| Alcon Research LLC | $420.00 | 1 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $270.95 | 6 | $0 (2023) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $196.33 | 9 | $0 (2021) |
| Allergan, Inc. | $160.60 | 3 | $0 (2021) |
| Johnson & Johnson Surgical Vision, Inc. | $158.20 | 7 | $0 (2022) |
| Aerie Pharmaceuticals, Inc. | $146.89 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,455 | 33 | Tarsus Pharmaceuticals, Inc. ($2,367) |
| 2023 | $556.86 | 18 | Bausch & Lomb Americas Inc. ($149.83) |
| 2022 | $353.38 | 13 | Alcon Vision LLC ($129.47) |
| 2021 | $487.23 | 19 | Alcon Vision LLC ($176.37) |
| 2020 | $385.05 | 12 | Sun Pharmaceutical Industries Inc. ($250.33) |
| 2019 | $367.87 | 14 | Allergan Inc. ($142.40) |
| 2018 | $1,122 | 3 | NEW WORLD MEDICAL,INC. ($999.83) |
| 2017 | $392.55 | 9 | Shire North American Group Inc ($133.01) |
All Payment Transactions
121 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/11/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $9.00 | General |
| Category: Ophthalmology | ||||||
| 11/11/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $16.06 | General |
| 10/23/2024 | Tarsus Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| 10/23/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/16/2024 | Alcon Vision LLC | — | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Ophthalmology | ||||||
| 10/10/2024 | Alcon Research LLC | — | Consulting Fee | Cash or cash equivalent | $420.00 | General |
| 10/01/2024 | Alcon Vision LLC | ARGOS (Device) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Ophthalmology | ||||||
| 10/01/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $9.23 | General |
| Category: Ophthalmology | ||||||
| 09/29/2024 | Tarsus Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.34 | General |
| 09/27/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $116.67 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 09/27/2024 | Tarsus Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $75.21 | General |
| 09/23/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $16.06 | General |
| 09/16/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $41.06 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 09/12/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $121.69 | General |
| Category: Ophthalmology | ||||||
| 09/11/2024 | Tarsus Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| 09/11/2024 | Tarsus Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $200.00 | General |
| 09/11/2024 | Tarsus Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $131.48 | General |
| 08/16/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $8.67 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 08/06/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $58.81 | General |
| Category: Ophthalmology | ||||||
| 07/16/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $78.84 | General |
| Category: Ophthalmology | ||||||
| 06/11/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $122.24 | General |
| Category: Ophthalmology | ||||||
| 06/10/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $13.20 | General |
| 05/16/2024 | Carl Zeiss Meditec USA, Inc. | — | Food and Beverage | In-kind items and services | $58.16 | General |
| 05/16/2024 | Rayner Intraocular Lenses Limited | Omidria (Drug), RayOne EMV, RayOne Spheric | Food and Beverage | Cash or cash equivalent | $22.38 | General |
| Category: Ophthalmology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Clinical Study to Evaluate the Safety and Effectiveness of the RxSight Light Adjustable Lens (LAL) in Subjects With Prior Corneal Refractive Surgery | RxSight Inc | $12.03 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 898 | 1,031 | $215,872 | $61,636 |
| 2022 | 8 | 570 | 668 | $141,908 | $49,376 |
| 2021 | 10 | 482 | 540 | $100,155 | $32,864 |
| 2020 | 6 | 228 | 249 | $48,843 | $19,265 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 214 | 315 | $44,654 | $19,396 | 43.4% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 186 | 196 | $41,724 | $14,862 | 35.6% |
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 40 | 48 | $36,102 | $6,134 | 17.0% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 59 | 59 | $21,921 | $4,750 | 21.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 58 | 58 | $15,900 | $4,605 | 29.0% |
| 92134 | Imaging of retina | Office | 2023 | 115 | 122 | $15,170 | $3,119 | 20.6% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 45 | 49 | $8,330 | $1,985 | 23.8% |
| 92133 | Imaging of optic nerve | Office | 2023 | 62 | 64 | $7,577 | $1,498 | 19.8% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 25 | 25 | $5,675 | $1,373 | 24.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $6,132 | $1,201 | 19.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 18 | $3,582 | $1,179 | 32.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 21 | 21 | $2,268 | $718.05 | 31.7% |
| 92250 | Photography of the retina | Office | 2023 | 28 | 29 | $5,671 | $538.18 | 9.5% |
| 92025 | Ct scan of cornea | Office | 2023 | 11 | 11 | $1,166 | $276.20 | 23.7% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 167 | 175 | $37,615 | $16,126 | 42.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 153 | 210 | $29,820 | $14,124 | 47.4% |
| 68761 | Closure of tear duct opening using plug | Office | 2022 | 41 | 73 | $33,760 | $9,394 | 27.8% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 39 | 39 | $14,781 | $4,054 | 27.4% |
| 92134 | Imaging of retina | Office | 2022 | 63 | 64 | $8,000 | $1,943 | 24.3% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 40 | 40 | $6,800 | $1,918 | 28.2% |
| 92133 | Imaging of optic nerve | Office | 2022 | 38 | 38 | $4,636 | $1,060 | 22.9% |
| 92250 | Photography of the retina | Office | 2022 | 29 | 29 | $6,496 | $756.29 | 11.6% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 134 | 190 | $26,980 | $11,517 | 42.7% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 132 | 134 | $28,676 | $10,808 | 37.7% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 59 | 59 | $22,361 | $5,587 | 25.0% |
About Dr. Rebecca Miller, OD
Dr. Rebecca Miller, OD is a Optometrist healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/30/2012. The National Provider Identifier (NPI) number assigned to this provider is 1932455722.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rebecca Miller, OD has received a total of $7,120 in payments from pharmaceutical and medical device companies, with $3,455 received in 2024. These payments were reported across 121 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($4,888).
As a Medicare-enrolled provider, Miller has provided services to 2,178 Medicare beneficiaries, totaling 2,488 services with total Medicare billing of $163,141. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Location Fort Worth, TX
- Active Since 07/30/2012
- Last Updated 01/16/2025
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1932455722
Products in Payments
- Ahmed Glaucoma Valve (Device) $999.83
- Clareon (Device) $271.27
- XIIDRA (Drug) $222.09
- XDEMVY (Drug) $218.00
- Cequa (Drug) $196.17
- PROKERA (Device) $189.26
- XELPROS (Drug) $153.82
- CEQUA (Drug) $141.02
- AcrySof IQ PanOptix (Device) $133.93
- RESTASIS (Drug) $124.15
- MIEBO (Drug) $123.73
- TYRVAYA (Drug) $122.06
- VYZULTA (Drug) $112.19
- Rhopressa (Drug) $104.40
- ALDEN SCLERAL ZENLENS (Device) $98.83
- AcrySof IQ PanOptix UV IOL (Device) $84.85
- DAILIES (Device) $80.42
- CIRRUS HD-OCT (Device) $76.11
- PROLENSA (Drug) $71.75
- TECNIS IOL (Device) $71.51
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Fort Worth
Dr. Robert Chu, O.d, O.D
Optometrist — Payments: $26,453
Dr. Kenneth King, Od, OD
Optometrist — Payments: $23,159
Jennifer Deakins, O.d, O.D
Optometrist — Payments: $22,919
Colette Manning, Od, OD
Optometrist — Payments: $17,412
Bryan Williams, Od, OD
Optometrist — Payments: $11,533
Dr. David Spivey, D.o, D.O
Optometrist — Payments: $9,878